Skip to content

CYTOSORBENTS CORPORATION: 10-K filed 2020-03-05

What CYTOSORBENTS CORPORATION reported in its annual report filed 2020-03-05 (fiscal FY 2019): 46 published measures, 152 facts as tagged in accession 0001104659-20-029712.

This filing

Form
10-K (annual report)
Filed
2020-03-05
Fiscal period
fiscal FY 2019
Accession
0001104659-20-029712 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-12-3127,382,510USD
At 2018-12-3134,196,763USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-12-3123,964,468USD
At 2018-12-3117,262,163USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-12-313,418,042USD
At 2018-12-3116,934,600USD
At 2017-12-3110,262,835USD
At 2016-12-311,337,459USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-12-3112,232,418USD
At 2018-12-3122,368,837USD
At 2017-12-3117,321,862USD
At 2016-12-315,245,178USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-19,265,644USD365
2018-01-01 to 2018-12-31-17,211,179USD365
2017-01-01 to 2017-12-31-8,460,799USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-16,758,782USD365
2018-01-01 to 2018-12-31-10,839,684USD365
2017-01-01 to 2017-12-31-6,460,705USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-12-31698,165USD365
2018-01-01 to 2018-12-31671,970USD365
2017-01-01 to 2017-12-31990,673USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-12-318,177,679USD365
2018-01-01 to 2018-12-3117,465,853USD365
2017-01-01 to 2017-12-3120,123,073USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-1,520,117USD365
2018-01-01 to 2018-12-31-1,520,264USD365
2017-01-01 to 2017-12-31-1,678,119USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-12-31-188,789,459USD
At 2018-12-31-169,523,815USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-1,092,446USD365
2018-01-01 to 2018-12-31-619,546USD365
2017-01-01 to 2017-12-31-676,739USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-12-311,925,325USD
At 2018-12-311,729,860USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,666,024USD365
2018-01-01 to 2018-12-314,437,250USD365
2017-01-01 to 2017-12-313,313,603USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-5,431,328USD92
2019-01-01 to 2019-12-31-18,974,064USD365
2019-07-01 to 2019-09-30-5,627,546USD92
2019-04-01 to 2019-06-30-3,629,997USD91
2019-01-01 to 2019-03-31-4,285,193USD90
2018-10-01 to 2018-12-31-5,585,266USD92
2018-01-01 to 2018-12-31-15,584,928USD365
2018-07-01 to 2018-09-30-2,710,620USD92
2018-04-01 to 2018-06-30-4,187,875USD91
2018-01-01 to 2018-03-31-3,101,167USD90
2017-10-01 to 2017-12-31-3,805,167USD92
2017-01-01 to 2017-12-31-9,842,598USD365
2017-07-01 to 2017-09-30-2,149,045USD92
2017-04-01 to 2017-06-30-2,330,908USD91
2017-01-01 to 2017-03-31-1,557,478USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-12-3120,901,529USD
At 2018-12-3128,264,087USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-12-319,936,267USD
At 2018-12-316,916,874USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-12-312,039,222USD
At 2018-12-311,485,812USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2019-12-313,361,412USD
At 2018-12-312,625,265USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-12-314,467,087USD
At 2018-12-313,943,119USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-01-01 to 2019-12-3136,559,618USD365
2018-01-01 to 2018-12-3130,599,436USD365
2017-01-01 to 2017-12-3119,474,992USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-12-312,113,897USD
At 2018-12-31833,133USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-10-01 to 2019-12-315,335,621USD92
2019-01-01 to 2019-12-3117,585,554USD365
2019-07-01 to 2019-09-304,398,733USD92
2019-04-01 to 2019-06-304,398,160USD91
2019-01-01 to 2019-03-313,453,040USD90
2018-10-01 to 2018-12-313,997,640USD92
2018-01-01 to 2018-12-3115,014,508USD365
2018-07-01 to 2018-09-303,690,278USD92
2018-04-01 to 2018-06-303,969,584USD91
2018-01-01 to 2018-03-313,357,006USD90
2017-10-01 to 2017-12-313,381,708USD92
2017-01-01 to 2017-12-319,632,394USD365
2017-07-01 to 2017-09-302,307,435USD92
2017-04-01 to 2017-06-302,084,216USD91
2017-01-01 to 2017-03-311,859,035USD90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-01-01 to 2019-12-3122,005,670USD365
2018-01-01 to 2018-12-3120,874,376USD365
2017-01-01 to 2017-12-3114,914,266USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-01-01 to 2019-12-3112,091,797USD365
2018-01-01 to 2018-12-317,723,028USD365
2017-01-01 to 2017-12-313,221,233USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-12-3132,616,107shares
At 2018-12-3131,774,139shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-12-31191,648,907USD
At 2018-12-31186,138,466USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-12-31525,978USD
At 2018-12-31288,175USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-12-311,070,762USD
At 2018-12-311,449,437USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-12-311,070,762USD
At 2018-12-311,449,437USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2019-12-3115,052,188USD
At 2018-12-319,941,194USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-12-315,584,973USD
At 2018-12-314,904,212USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-12-313,659,648USD
At 2018-12-313,174,352USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-12-313,484,894USD
At 2018-12-312,753,379USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-12-31629,186USD
At 2018-12-31479,783USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-12-312,088,127USD
At 2018-12-311,118,998USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2019-12-31171,842USD
At 2018-12-3142,219USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2019-12-31393,897USD
At 2018-12-3121,856USD
At 2017-12-3119,820USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-19,027,841USD365
2018-01-01 to 2018-12-31-16,562,019USD365
2017-01-01 to 2017-12-31-9,720,468USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-3,949,351USD92
2019-01-01 to 2019-12-31-19,265,644USD365
2019-07-01 to 2019-09-30-6,885,061USD92
2019-04-01 to 2019-06-30-3,547,405USD91
2019-01-01 to 2019-03-31-4,883,827USD90
2018-10-01 to 2018-12-31-5,403,178USD92
2018-01-01 to 2018-12-31-17,211,179USD365
2018-07-01 to 2018-09-30-3,004,764USD92
2018-04-01 to 2018-06-30-5,821,202USD91
2018-01-01 to 2018-03-31-2,982,035USD90
2017-10-01 to 2017-12-31-3,147,019USD92
2017-01-01 to 2017-12-31-8,796,530USD365
2017-07-01 to 2017-09-30-2,054,279USD92
2017-04-01 to 2017-06-30-2,070,359USD91
2017-01-01 to 2017-03-31-1,524,873USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-12-31495,728USD365
2018-01-01 to 2018-12-31329,469USD365
2017-01-01 to 2017-12-31177,776USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-1,384,026USD365
2018-01-01 to 2018-12-31-2,245,797USD365
2017-01-01 to 2017-12-31705,060USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,059,541USD365
2018-01-01 to 2018-12-31891,386USD365
2017-01-01 to 2017-12-31634,608USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-12-3114,126,525USD365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-01-01 to 2019-12-31906,000USD365
2018-01-01 to 2018-12-31805,000USD365
2017-01-01 to 2017-12-31676,000USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-31642,171USD365
2018-01-01 to 2018-12-311,847,848USD365
2017-01-01 to 2017-12-31649,318USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,284,848USD365
2018-01-01 to 2018-12-3156,751USD365
2017-01-01 to 2017-12-31-57,320USD365

Inspect the source

Entity
CYTOSORBENTS CORPORATION / CIK 0001175151
Captured
2026-09-20T07:44:44.168Z
SEC response SHA-256
8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))